About This Calculator

This Epoprostenol Infusion Calculator helps healthcare professionals perform critical dosing calculations for epoprostenol therapy, a cornerstone in the management of pulmonary arterial hypertension (PAH). The tool streamlines the process of converting between a prescribed dose (in ng/kg/min) and the required infusion pump rate (in mL/hr), ensuring accurate medication administration.

Outputs Explained

Based on the inputs provided, the calculator generates the following key values for clinical use:

• Infusion Rate (mL/hr): When calculating from a dose, this is the final pump rate required to deliver the prescribed amount of epoprostenol.
• Patient Dose (ng/kg/min): When calculating from a rate, this is the actual dose the patient is receiving based on the current pump setting.
• Calculation Summary: A concise summary is provided, including the patient’s weight in kilograms, the final drug concentration in ng/mL, and the total dose rate in ng/min, which is useful for documentation and cross-verification.

How to Use the Calculator

Follow these steps to ensure an accurate calculation:

1. Select Calculation Mode: Choose whether you need to calculate the ‘Infusion Rate’ from a known dose or calculate the ‘Dose’ from a known infusion rate.
2. Enter Patient Weight: Input the patient’s weight and select the correct unit (kg or lbs). The calculator will automatically convert lbs to kg for the formula.
3. Input Drug Concentration: You can either calculate the final concentration by entering the total amount of drug (mg) and the total final volume (mL) of the infusion bag, or you can enter the final concentration (ng/mL) directly if it’s already known.
4. Enter Known Variable: Input either the prescribed dose (ng/kg/min) or the current infusion rate (mL/hr), depending on your selected mode.
5. Calculate and Review: Click the “Calculate” button to see the result. Always verify the output against the clinical context and institutional protocols.

Dosing Overview

Epoprostenol dosing is highly individualized and requires careful titration. It is administered as a continuous intravenous infusion due to its extremely short half-life of approximately 6 minutes. The typical starting dose is 2 ng/kg/min, which is then gradually increased based on the patient’s tolerance and clinical response (e.g., improvement in symptoms, hemodynamics) while monitoring for dose-limiting side effects like hypotension, flushing, and headache.

Switching Therapy

Transitioning a patient from epoprostenol to another prostacyclin analog (e.g., intravenous or subcutaneous treprostinil) is a high-risk procedure that must be performed in a specialized center with experienced personnel. It requires a carefully planned overlap period with gradual titration of both medications to avoid rebound pulmonary hypertension or hemodynamic instability.

Missed Dose or Infusion Interruption

Any interruption in epoprostenol infusion is a medical emergency. Due to its short half-life, abrupt cessation can lead to rapid worsening of pulmonary hypertension, right heart failure, and potentially death. Patients must have immediate access to a backup infusion pump, a spare drug cassette, and emergency contact information. All caregivers must be trained to manage pump failures or catheter issues promptly.

Safety Alerts

• Rebound Pulmonary Hypertension: Abrupt withdrawal or a significant decrease in the dose of epoprostenol can be fatal. Ensure the infusion is continuous and uninterrupted.
• Catheter-Related Bloodstream Infections (CRBSI): As a long-term central venous therapy, there is a significant risk of infection. Strict aseptic technique is mandatory during all aspects of catheter care and medication preparation.
• Hypotension: Epoprostenol is a potent vasodilator and can cause systemic hypotension, especially during dose initiation and titration. Blood pressure must be monitored closely.
• Side Effects: Common adverse effects include flushing, headache, jaw pain, nausea, vomiting, and diarrhea. These are often dose-dependent and may limit the rate of dose escalation.

Frequently Asked Questions (FAQ)

Why is patient weight crucial for epoprostenol dosing?

Epoprostenol is dosed based on body weight (ng/kg/min) to normalize the dose across patients of different sizes. An accurate, current weight is essential for safe and effective administration, as an incorrect weight will lead to underdosing or overdosing.

What is the difference between calculating concentration and entering it directly?

Calculating concentration is useful when you are preparing the infusion and know the amount of drug (mg) added to a specific volume of diluent (mL). Entering concentration directly is for situations where the final concentration (ng/mL) is already known, such as with a pre-mixed bag or standard hospital protocol.

Can I use this calculator for other drugs like treprostinil or iloprost?

No. This calculator is specifically designed for the units and dosing conventions of epoprostenol. Other prostacyclin analogs have different potencies, dosing units, and administration protocols. Using this tool for other medications would result in dangerous dosing errors.

What does ‘ng/kg/min’ mean?

It stands for nanograms per kilogram per minute. It is the amount of drug (in nanograms) that is infused for each kilogram of the patient’s body weight every minute.

Why is the infusion rate often a decimal number?

The infusion rate is a precise calculation based on dose, weight, and concentration. To deliver the exact prescribed dose, modern infusion pumps can be programmed with decimal points (e.g., 2.1 mL/hr) to ensure accuracy.

How do I know if the “Total Final Volume” includes the drug volume?

The “Total Final Volume” should be the complete volume in the infusion bag after the drug has been added to the diluent. Always follow your institution’s pharmacy and nursing protocols for this definition.

What should I do if the calculator shows an error?

First, double-check all your inputs for accuracy and ensure they are positive numbers. Common errors include missing values or using commas instead of decimal points. The tool requires a positive value for weight, dose/rate, and concentration components.

How often is the epoprostenol dose adjusted?

Dose adjustments (titration) depend on the clinical setting. In an initial hospitalization, it may be adjusted every few hours. For stable outpatients, adjustments are less frequent and are based on clinical assessments during follow-up visits with a PAH specialist.

References

• FLOLAN (epoprostenol sodium) for injection Prescribing Information. GlaxoSmithKline. Revised: 09/2023. Accessed via DailyMed. View Source
• VELETRI (epoprostenol) for injection Prescribing Information. Actelion Pharmaceuticals US, Inc. Revised: 05/2018. Accessed via FDA. View Source
• Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37(1):67-119. View on PubMed
• Pulmonary Hypertension Association. Treatments for Pulmonary Hypertension. Accessed 2024. View Source